Report
Positron emission tomography (PET) in malignant melanoma
Report documents
-
Executive summary of the final report
Positron emission tomography (PET) in malignant melanoma
-
Final report
Positron emission tomography (PET) in malignant melanoma
-
Documentation and evaluation of comments on the preliminary report
Positron emission tomography (PET) in malignant melanoma
-
Executive summary of the preliminary report
Positron emission tomography (PET) in malignant melanoma
-
Preliminary report
Positron emission tomography (PET) in malignant melanoma
-
Report plan version 1.0
Positron emission tomography (PET) in malignant melanoma
-
Erratum to the documentation and evaluation of comments on the preliminary report plan
Positron emission tomography (PET) in malignant melanoma
-
Documentation and appraisal of comments on the preliminary report plan
Positron emission tomography (PET) in malignant melanoma
-
Preliminary report plan
Positron emission tomography (PET) in malignant melanoma
Press releases
Benefit of PET in malignant melanoma is unclear
Robust studies are lacking / IQWiG calls for comparative studies of high methodological quality
Additional information
IQWiG health information
IQWiG health information
Positron emission tomography (PET) scans are used to see metabolic activity in the tissue of the body. To do this, multiple images are created to show that part of the body layer by layer.
Project details
- Project no.
- D06-01F
- Commission
- Commission awarded on 19.12.2006 by the Federal Joint Committee (GBA).
- Report type
- Report
- Status
- Commission completed
- Department/Division
- Non-Drug Interventions
- Topic
- Cancer, Diagnostics